Glycemic control in hospitalized patients not in intensive care: Beyond sliding-scale insulin

American Family Physician

Volumn 81, Issue 9, 2010, Pages 1130-1135

  Nau, Konrad C ^a   Lorenzetti, Rosemarie C ^a   Cucuzzella, Mark ^a   Devine, Timothy ^a   Kline, Jonathan ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; ISOPHANE INSULIN; LONG ACTING INSULIN; ORAL ANTIDIABETIC AGENT; SHORT ACTING DRUG; ANTIDIABETIC AGENT;

ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL PROTOCOL; DIABETES MELLITUS; DIETARY INTAKE; DRUG EFFICACY; DRUG SAFETY; ENDOTHELIAL DYSFUNCTION; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTENSIVE CARE; LENGTH OF STAY; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; CLINICAL PATHWAY; DRUG ADMINISTRATION; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HOSPITAL PATIENT; MONITORING; PRACTICE GUIDELINE; UNITED STATES;

BLOOD GLUCOSE; CRITICAL PATHWAYS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION SCHEDULE; HOSPITALIZATION; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INPATIENTS; INSULIN; MONITORING, PHYSIOLOGIC; PRACTICE GUIDELINES AS TOPIC; UNITED STATES;

EID: 77952303961     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. National diabetes fact sheet, 2007. http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2007.pdf. Accessed January 24, 2009.
2. American Diabetes Association. Economic costs of diabetes in the U.S. in 2007 [published correction appears in Diabetes Care. 2008;31(6):1271]. Diabetes Care. 2008;31(3):596-615.
3. Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project (HCUP). http://hcupnet.ahrq.gov/HCUPnet.jsp. Accessed January 24, 2009.
4. Boord JB, Greevy RA, Braithwaite SS, et al. Evaluation of hospital glycemic control at US academic medical centers. J Hosp Med. 2009; 4(1):35-44.
5. Braithwaite SS, Magee M, Sharretts JM, Schnipper JL, Amin A, Maynard G; Society of Hospital Medicine Glycemic Control Task Force. The case for supporting inpatient glycemic control programs now: the evidence and beyond. J Hosp Med. 2008;3(5 suppl):6-16.
6. Newton CA, Young S. Financial implications of glycemic control: results of an inpatient diabetes management program. Endocr Pract. 2006;12(suppl 3):43-48.
7. Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009;32(6):1119-1131.
8. American Diabetes Association. Standards of medical care in diabetes-2008. Diabetes Care. 2008;31(suppl 1):S12-54.
9. Schnipper JL, Magee M, Larsen K, Inzucchi SE, Maynard G. Society of Hospital Medicine Glycemic Control Task Force summary: practical recommendations for assessing the impact of glycemic control efforts. J Hosp Med. 2008;3(5 suppl):66-75.
10. Joslin EP. A Diabetic Manual for the Mutual Use of Doctor and Patient. 5th ed. Philadelphia, Pa.: Lea & Febiger; 1934:108.
11. MacMillan DR. The fallacy of insulin adjustment by the sliding scale. J Ky Med Assoc. 1970;68(9):577-579.
12. Browning LA, Dumo P. Sliding-scale insulin: an antiquated approach to glycemic control in hospitalized patients. Am J Health Syst Pharm. 2004;61(15):1611-1614.
13. Hirsch IB. Sliding scale insulin-time to stop sliding. JAMA. 2009; 301(2):213-214.
14. Golightly LK, Jones MA, Hamamura DH, Stolpman NM, McDermott MT. Management of diabetes mellitus in hospitalized patients: efficiency and effectiveness of sliding-scale insulin therapy. Pharmacotherapy. 2006;26(10):1421-1432.
15. Queale WS, Seidler AJ, Brancati FL. Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. Arch Intern Med. 1997;157(5):545-552.
16. Michota F. What are the disadvantages of sliding-scale insulin? J Hosp Med. 2007;2(suppl 1):20-22.
17. Umpierrez GE, Palacio A, Smiley D. Sliding scale insulin use: myth or insanity? Am J Med. 2007;120(7):563-567.
18. Maynard G, Lee J, Phillips G, Fink E, Renvall M. Improved inpatient use of basal insulin, reduced hypoglycemia, and improved glycemic control: effect of structured subcutaneous insulin orders and an insulin management algorithm. J Hosp Med. 2009;4(1):3-15.
19. Datta S, Qaadir A, Villanueva G, Baldwin D. Once-daily insulin glargine versus 6-hour sliding scale regular insulin for control of hyperglycemia after a bariatric surgical procedure: a randomized clinical trial. Endocr Pract. 2007;13(3):225-231.
20. Umpierrez GE, Smiley D, Zisman A, et al. Randomized study of basalbolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care. 2007;30(9):2181-2186.
21. Schnipper JL, Ndumele CD, Liang CL, Pendergrass ML. Effects of a subcutaneous insulin protocol, clinical education, and computerized order set on the quality of inpatient management of hyperglycemia: results of a clinical trial. J Hosp Med. 2009;4(1):16-27.
22. Maynard G, Wesorick DH, O'Malley C, Inzucchi SE; Society of Hospital Medicine Glycemic Control Task Force. Subcutaneous insulin order sets and protocols: effective design and implementation strategies. J Hosp Med. 2008;3(5 suppl):29-41.
23. Furnary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract. 2004;10(suppl 2): 21-33.
24. O'Malley CW, Emanuele M, Halasyamani L, Amin AN; Society of Hospital Medicine Glycemic Control Task Force. Bridge over troubled waters: safe and effective transitions of the inpatient with hyperglycemia. J Hosp Med. 2008;3(5 suppl):55-65.
25. Barrett BJ, Parfrey PS. Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med. 2006;354(4):379-386.
26. Clement S, Braithwaite SS, Magee MF, et al.; American Diabetes Association Diabetes in Hospitals Writing Committee. Management of diabetes and hyperglycemia in hospitals [published corrections appear in Diabetes Care. 2004;27(5):1255, and Diabetes Care. 2004;27(3):856]. Diabetes Care. 2004;27(2):553-591.
27. Schmeltz LR, DeSantis AJ, Schmidt K, et al. Conversion of intravenous insulin infusions to subcutaneously administered insulin glargine in patients with hyperglycemia. Endocr Pract. 2006;12(6):641-650.
28. American Association of Clinical Endocrinologists. Challenges in effective discharge planning for hospitalized patients with diabetes. 2007. http://resources.aace.com/PDF/Section_07-Final-Transition-Inpatient_to_Outpatient/Challenges_in_Effective_Discharge_for_Diabetes_Patients.PPT. Accessed January 24, 2009.
29. Department of Health and Human Services, Centers for Medicare and Medicaid Services (CMS). Subject: fiscal year (FY) 2009 inpatient prospective payment system (IPPS), long term care hospital (LTCH) PPS, and inpatient psychiatric facility (IPF) PPS changes. CMS manual system. Pub 100-04 Medicare claims processing. Transmittal 1610. Change request 6189. October 2008. http://www.cms.hhs.gov/transmittals/downloads/R1610CP.pdf. Accessed January 24, 2009.